Literature DB >> 12078886

Long-term results of arthroscopic synovectomy for seropositive rheumatoid arthritis: 6-16 year review.

C E Gibbons1, H S Gosal, J Bartlett.   

Abstract

We prospectively studied a consecutive series of 25 knees (21 patients) treated with arthroscopic synovectomy for seropositive rheumatoid arthritis. All patients had pain and swelling and were in the early stages of the disease process (Larsen grade 2 or less). Three patients were lost to follow-up. At a mean of 8 years from operation two knees underwent total knee replacement with another two knees required a further arthroscopic synovectomy. One patient continued to experience intermittent mild synovitis. The range of movement was maintained or improved by surgery in 73% of cases but radiological evidence of degenerative change was seen in all knees. We discuss the technical difficulties associated with arthroscopic synovectomy that were associated with a small complication rate. In appropriately selected patients unresponsive to medical therapy, arthroscopic synovectomy can give safe and reliable results.

Entities:  

Mesh:

Year:  2002        PMID: 12078886      PMCID: PMC3620874          DOI: 10.1007/s00264-001-0309-1

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  3 in total

Review 1.  Rheumatoid synovectomy: does the surgical approach matter?

Authors:  Peter N Chalmers; Seth L Sherman; Bradley S Raphael; Edwin P Su
Journal:  Clin Orthop Relat Res       Date:  2011-01-07       Impact factor: 4.176

2.  Improved quality of life and joint functions in patients with knee rheumatoid arthritis who underwent five portal arthroscopic synovectomy.

Authors:  Wen-Xin Liu; Yao Jiang; Qing-Xiang Hu; Xie-Bo You
Journal:  PeerJ       Date:  2018-04-30       Impact factor: 2.984

3.  Comparison of arthroscopic, radioactive and combined synovectomy in the treatment of chronic non-specific knee synovitis.

Authors:  Ibrahim Karaman; Ahmet Guney; Fatih Dogar; Ibrahim Halil Kafadar; Okkes Bilal; Mithat Oner; Mustafa Kula
Journal:  Med Princ Pract       Date:  2014-08-29       Impact factor: 1.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.